Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
Identifieur interne : 003827 ( Main/Exploration ); précédent : 003826; suivant : 003828Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
Auteurs : V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]Source :
- Clinical neuropharmacology [ 0362-5664 ] ; 1999.
Descripteurs français
- Pascal (Inist)
- Antagoniste dopamine, Antagoniste, Agoniste, Récepteur dopaminergique D1, Stimulant dopaminergique, Récepteur dopaminergique, Comportement, Parkinson maladie, Apomorphine, Lévodopa, Association médicamenteuse, Animal, Singe, Long terme, Voie orale, Latence réponse, Durée action, Dose répétée, Activité biologique, SCH 23390, NNC 010112, Antiparkinsonien.
- Wicri :
- topic : Singe.
English descriptors
- KwdEn :
- Agonist, Animal, Antagonist, Antiparkinson agent, Behavior, Biological activity, D1 Dopamine receptor, Dopamine agonist, Dopamine antagonist, Dopamine receptor, Drug combination, Duration of action, Levodopa, Long term, Monkey, Multiple dose, Oral administration, Parkinson disease, Response latency.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000D27
- to stream PascalFrancis, to step Curation: 001196
- to stream PascalFrancis, to step Checkpoint: 000C60
- to stream Main, to step Merge: 003E13
- to stream Main, to step Curation: 003827
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effect of the selective D<sub>1</sub>
antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys</title>
<author><name sortKey="Doan, V D" sort="Doan, V D" uniqKey="Doan V" first="V. D." last="Doan">V. D. Doan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grondin, R" sort="Grondin, R" uniqKey="Grondin R" first="R." last="Grondin">R. Grondin</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abdallah Hadj Tahar" sort="Abdallah Hadj Tahar" uniqKey="Abdallah Hadj Tahar" last="Abdallah Hadj Tahar">ABDALLAH HADJ TAHAR</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gregoire, L" sort="Gregoire, L" uniqKey="Gregoire L" first="L." last="Gregoire">L. Gregoire</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0526518</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0526518 INIST</idno>
<idno type="RBID">Pascal:99-0526518</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D27</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001196</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000C60</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000C60</idno>
<idno type="wicri:doubleKey">0362-5664:1999:Doan V:effect:of:the</idno>
<idno type="wicri:Area/Main/Merge">003E13</idno>
<idno type="wicri:Area/Main/Curation">003827</idno>
<idno type="wicri:Area/Main/Exploration">003827</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effect of the selective D<sub>1</sub>
antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys</title>
<author><name sortKey="Doan, V D" sort="Doan, V D" uniqKey="Doan V" first="V. D." last="Doan">V. D. Doan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grondin, R" sort="Grondin, R" uniqKey="Grondin R" first="R." last="Grondin">R. Grondin</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Abdallah Hadj Tahar" sort="Abdallah Hadj Tahar" uniqKey="Abdallah Hadj Tahar" last="Abdallah Hadj Tahar">ABDALLAH HADJ TAHAR</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gregoire, L" sort="Gregoire, L" uniqKey="Gregoire L" first="L." last="Gregoire">L. Gregoire</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neurobiology Research Center, Enfant-Jesus Hospital and Faculty of Medicine, Laval University</s1>
<s2>Québec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Québec</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Animal</term>
<term>Antagonist</term>
<term>Antiparkinson agent</term>
<term>Behavior</term>
<term>Biological activity</term>
<term>D1 Dopamine receptor</term>
<term>Dopamine agonist</term>
<term>Dopamine antagonist</term>
<term>Dopamine receptor</term>
<term>Drug combination</term>
<term>Duration of action</term>
<term>Levodopa</term>
<term>Long term</term>
<term>Monkey</term>
<term>Multiple dose</term>
<term>Oral administration</term>
<term>Parkinson disease</term>
<term>Response latency</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antagoniste dopamine</term>
<term>Antagoniste</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique D1</term>
<term>Stimulant dopaminergique</term>
<term>Récepteur dopaminergique</term>
<term>Comportement</term>
<term>Parkinson maladie</term>
<term>Apomorphine</term>
<term>Lévodopa</term>
<term>Association médicamenteuse</term>
<term>Animal</term>
<term>Singe</term>
<term>Long terme</term>
<term>Voie orale</term>
<term>Latence réponse</term>
<term>Durée action</term>
<term>Dose répétée</term>
<term>Activité biologique</term>
<term>SCH 23390</term>
<term>NNC 010112</term>
<term>Antiparkinsonien</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Singe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Doan, V D" sort="Doan, V D" uniqKey="Doan V" first="V. D." last="Doan">V. D. Doan</name>
</noRegion>
<name sortKey="Abdallah Hadj Tahar" sort="Abdallah Hadj Tahar" uniqKey="Abdallah Hadj Tahar" last="Abdallah Hadj Tahar">ABDALLAH HADJ TAHAR</name>
<name sortKey="Bedard, P J" sort="Bedard, P J" uniqKey="Bedard P" first="P. J." last="Bedard">P. J. Bedard</name>
<name sortKey="Gregoire, L" sort="Gregoire, L" uniqKey="Gregoire L" first="L." last="Gregoire">L. Gregoire</name>
<name sortKey="Grondin, R" sort="Grondin, R" uniqKey="Grondin R" first="R." last="Grondin">R. Grondin</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003827 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003827 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:99-0526518 |texte= Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys }}
This area was generated with Dilib version V0.6.29. |